Skip to Content

Roche Holding AG Bearer Shares RHHBF

Morningstar Rating
$300.00 −2.00 (0.66%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

RHHBF is trading at a 126% premium.
Price
$300.50
Fair Value
$714.87
Uncertainty
High
1-Star Price
$256.56
5-Star Price
$425.33
Economic Moat
Txsg
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RHHBF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$302.00
Day Range
$300.00300.00
52-Week Range
$243.42347.50
Bid/Ask
$282.00 / $349.81
Market Cap
$239.17 Bil
Volume/Avg
50 / 135

Key Statistics

Price/Earnings (Normalized)
13.77
Price/Sales
3.59
Dividend Yield (Trailing)
3.62%
Dividend Yield (Forward)
3.62%
Total Yield
3.62%

Company Profile

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Sector
Healthcare
Industry
Drug Manufacturers - General
Stock Style Box
Large Core
Total Number of Employees
103,605

Competitors

Valuation

Metric
RHHBF
MRK
ABBV
Price/Earnings (Normalized)
13.7758.8715.54
Price/Book Value
6.858.0237.55
Price/Sales
3.595.305.55
Price/Cash Flow
13.1918.6316.05
Price/Earnings
RHHBF
MRK
ABBV

Financial Strength

Metric
RHHBF
MRK
ABBV
Quick Ratio
0.990.680.72
Current Ratio
1.351.250.94
Interest Coverage
14.933.973.95
Quick Ratio
RHHBF
MRK
ABBV

Profitability

Metric
RHHBF
MRK
ABBV
Return on Assets (Normalized)
17.03%5.22%14.14%
Return on Equity (Normalized)
53.42%13.56%172.29%
Return on Invested Capital (Normalized)
26.30%8.29%27.87%
Return on Assets
RHHBF
MRK
ABBV
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - General Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Eli Lilly and Co
LLY
DdprpsylhXckt$853.9 Bil
Johnson & Johnson
JNJ
HxflqmvLdcxj$360.7 Bil
Merck & Co Inc
MRK
FkzgfprdGzl$323.6 Bil
AbbVie Inc
ABBV
ZtgpdjzYzcp$300.7 Bil
AstraZeneca PLC ADR
AZN
PtnljxzvFljk$245.6 Bil
Roche Holding AG ADR
RHHBY
GwsmhjgbvWnl$229.9 Bil
Novartis AG ADR
NVS
JlpwpbxcFntd$227.8 Bil
Amgen Inc
AMGN
XwzkjvkwrHtjp$177.5 Bil
Pfizer Inc
PFE
LpydzhlYzdl$163.9 Bil
Sanofi SA ADR
SNY
SxfqfwmxcTyr$128.4 Bil

Sponsor Center